https://www.cnbctv18.com/market/sun-pharma-share-price-subsidiary-signs-licensing-agreement-aclaris-alopecia-treatment-deuruxolitinib-18498741.htm
The agreement includes an upfront payment of $15 milion, regulatory and commercial milestones and royalties.
Create an account or login to join the discussion